New plant breeding technologies (NPBTs), including genetically modified and gene-edited crops, offer large potentials for sustainable agricultural development and food security while addressing shortcomings of the Green Revolution. This article reviews potentials, risks, and actually observed impacts of NPBTs. Regulatory aspects are also discussed. While the science is exciting and some clear benefits are already observable, overregulation and public misperceptions may obstruct efficient development and use of NPBTs. Overregulation is particularly observed in Europe, but also affects developing countries in Africa and Asia, which could benefit the most from NPBTs. Regulatory reforms and a more science-based public debate are required.
L’ouest du Rio Grande do Sul est dominé par la culture du soja, du riz et par l’élevage bovin. Dans la partie sableuse, le milieu est affecté par des phénomènes d’érosion produisant des modelés éoliens spectaculaires (arenização) rappelant dans l’imaginaire...
De nombreux agriculteurs africains pratiquent des formes d'agriculture potentiellement qualifiables de "?biologiques?". Pourtant, la capacité de l'agriculture biologique à répondre aux enjeux de la sécurité alimentaire en Afrique est encore mal connue, car il existe peu de références expérimentales disponibles...
Past studies showing that barriers to farmers’ adaptation behaviors are focused on their socio-economic factors and resource availability. Meanwhile, psychological and social considerations are sparingly mentioned, especially for the related studies in developing countries. This study investigates the impact of...
One of the key challenges for agriculture today is feeding an increasing population without contributing to climate change. Increasingly, digital agriculture is discussed as a new sociotechnical regime that could help limit emissions for farmers worldwide. While sustainability is an important issue,...
Biotechnology offers great potential to contribute to sustainable agricultural growth, food security and poverty alleviation in developing countries. Yet there are economic and institutional constraints at national and international levels that inhibit the poor people's access to appropriate biotechnological innovations....
